UK Obesity Rate: A Persistent Public Health Challenge
Obesity remains one of the United Kingdom’s most persistent public health challenges. In England, the 2024 Health Survey for England…
Category: Research Insights
Semaglutide Linked to Fewer Asthma Attacks: What the New Research Found
Semaglutide, the active ingredient in medicines such as Ozempic and Wegovy, may have an unexpected connection with respiratory health. New…
TOFA: Experimental Obesity Drug Makes Mice Burn More Fat Without Eating Less
An experimental compound called TOFA could point toward a different strategy for treating obesity: increasing the body’s energy expenditure rather…
Semaglutide Brand Names: Wegovy, Ozempic and Rybelsus Explained
Semaglutide is a prescription medicine that belongs to the GLP-1 receptor agonist class. It has become one of the most…
Top Obesity Biotech Companies in 2026: Beyond Novo Nordisk and Eli Lilly
The obesity drug race is no longer limited to Novo Nordisk and Eli Lilly. A growing group of biotech companies…
Why Is It So Hard to Stop Eating Fatty Foods? A New Brain Study Offers a Clue
Why can some people keep eating fatty foods even after they have consumed enough calories? New research suggests part of…
How Fast-Food Smells and Visuals Can Hijack Your Brain: What Studies Show
You may have just eaten and feel completely full. Then you walk past a burger outlet, smell French fries, see…